After ousting CEO, Novo Nordisk reclaims crown as largest European company

Dow Jones

06/13

MW After ousting CEO, Novo Nordisk reclaims crown as largest European company

By Steve Goldstein

Novo Nordisk's shock decision to oust its chief executive has resulted in the Ozempic maker once again becoming Europe's largest by market capitalization.

Novo Nordisk's ADR $(NVO)$ (DK:NOVO.B), at Thursday's close, valued the drugmaker at $357.9 billion, while SAP $(SAP)$ (XE:SAP), the German software company, is worth $353 billion.

Last month, Novo Nordisk said Lars Fruergaard Jørgensen was stepping down after eight years running the company, after the charitable foundation that is its main owner called for change. Novo Nordisk's stock had faltered as it encountered competition from rival Eli Lilly and a key developmental drug didn't perform as well at a trial as hoped.

Though not immediately, that move to push out its CEO sparked a 28% rally in the Copenhagen-listed shares.

The Financial Times has reported that an activist investor, Parvus, was building a stake to help influence the appointment of a new CEO.

-Steve Goldstein

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

June 13, 2025 04:48 ET (08:48 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

应版权方要求，你需要登录查看该内容

登录 / 注册

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2543509250"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2543509250\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2543509250?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-06-13 16:48","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2543509250","market":"sh","top_or_hot":-1,"title":"After ousting CEO, Novo Nordisk reclaims crown as largest European company","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nMW After ousting CEO, Novo Nordisk reclaims crown as largest European company\n</p>\n<p>\n  By Steve Goldstein \n</p>\n<p>\n     Novo Nordisk's shock decision to oust its chief executive has resulted in the Ozempic maker once again becoming Europe's largest by market capitalization. \n</p>\n<p>\n     Novo Nordisk's ADR <a href=\"https://laohu8.com/S/NVO\">$(NVO)$</a> (DK:NOVO.B), at Thursday's close, valued the drugmaker at $357.9 billion, while SAP <a href=\"https://laohu8.com/S/SAP\">$(SAP)$</a> (XE:SAP), the German software company, is worth $353 billion. \n</p>\n<p>\n     Last month, Novo Nordisk said Lars Fruergaard Jørgensen was stepping down after eight years running the company, after the charitable foundation that is its main owner called for change. Novo Nordisk's stock had faltered as it encountered competition from rival Eli Lilly and a key developmental drug didn't perform as well at a trial as hoped. \n</p>\n<p>\n     Though not immediately, that move to push out its CEO sparked a 28% rally in the Copenhagen-listed shares. \n</p>\n<p>\n     The Financial Times has reported that an activist investor, Parvus, was building a stake to help influence the appointment of a new CEO. \n</p>\n<p>\n     -Steve Goldstein \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 13, 2025 04:48 ET (08:48 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After ousting CEO, Novo Nordisk reclaims crown as largest European company</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter ousting CEO, Novo Nordisk reclaims crown as largest European company\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-06-13 16:48</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nMW After ousting CEO, Novo Nordisk reclaims crown as largest European company\n</p>\n<p>\n  By Steve Goldstein \n</p>\n<p>\n     Novo Nordisk's shock decision to oust its chief executive has resulted in the Ozempic maker once again becoming Europe's largest by market capitalization. \n</p>\n<p>\n     Novo Nordisk's ADR <a href=\"https://laohu8.com/S/NVO\">$(NVO)$</a> (DK:NOVO.B), at Thursday's close, valued the drugmaker at $357.9 billion, while SAP <a href=\"https://laohu8.com/S/SAP\">$(SAP)$</a> (XE:SAP), the German software company, is worth $353 billion. \n</p>\n<p>\n     Last month, Novo Nordisk said Lars Fruergaard Jørgensen was stepping down after eight years running the company, after the charitable foundation that is its main owner called for change. Novo Nordisk's stock had faltered as it encountered competition from rival Eli Lilly and a key developmental drug didn't perform as well at a trial as hoped. \n</p>\n<p>\n     Though not immediately, that move to push out its CEO sparked a 28% rally in the Copenhagen-listed shares. \n</p>\n<p>\n     The Financial Times has reported that an activist investor, Parvus, was building a stake to help influence the appointment of a new CEO. \n</p>\n<p>\n     -Steve Goldstein \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 13, 2025 04:48 ET (08:48 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NVO","symbol_name":"诺和诺德","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2543509250","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2543509250","pubTimestamp":1749804480,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Novo Nordisk's shock decision to oust its chief executive has resulted in the Ozempic maker once again becoming Europe's largest by market capitalization.Novo Nordisk's ADR  , at Thursday's close, valued the drugmaker at $357.9 billion, while SAP  , the German software company, is worth $353 billion.Last month, Novo Nordisk said Lars Fruergaard Jrgensen was stepping down after eight years running the company, after the charitable foundation that is its main owner called for change. Novo Nordisk's stock had faltered as it encountered competition from rival Eli Lilly and a key developmental drug didn't perform as well at a trial as hoped.Though not immediately, that move to push out its CEO sparked a 28% rally in the Copenhagen-listed shares.The Financial Times has reported that an activist investor, Parvus, was building a stake to help influence the appointment of a new CEO.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independent","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"NVO":"诺和诺德","BK4613":"AI应用软件","BK4023":"应用软件","BK4585":"ETF&股票定投概念","SAP":"SAP SE","BK4532":"文艺复兴科技持仓","BK4588":"碎股","BK4599":"减肥药","LU0154236417.USD":"BGF US FLEXIBLE EQUITY \"A2\" ACC","LU1093756168.USD":"FRANKLIN K2 ALTERNATIVE STRATEGIES \"A\" (USD) ACC","IE00BZ1G4Q59.USD":"LEGG MASON CLEARBRIDGE US EQUITY SUSTAINABILITY LEADER \"A\"(USD) INC (A)","BK4007":"制药","IE00BKVL7J92.USD":"Legg Mason ClearBridge - US Equity Sustainability Leaders A Acc USD","LU1093756325.SGD":"FTIF - Franklin K2 Alt Strat Fd A (acc) SGD-H1","BK4528":"SaaS概念"},"translate_title":"罢免首席执行官后，诺和诺德重新夺回欧洲最大公司桂冠","themeId":"4d217f261842c16c97637fa9633c3863","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NVO":1,"SAP":0.9},"content_text":"MW After ousting CEO, Novo Nordisk reclaims crown as largest European company\n\n\n  By Steve Goldstein \n\n\n     Novo Nordisk's shock decision to oust its chief executive has resulted in the Ozempic maker once again becoming Europe's largest by market capitalization. \n\n\n     Novo Nordisk's ADR $(NVO)$ (DK:NOVO.B), at Thursday's close, valued the drugmaker at $357.9 billion, while SAP $(SAP)$ (XE:SAP), the German software company, is worth $353 billion. \n\n\n     Last month, Novo Nordisk said Lars Fruergaard Jørgensen was stepping down after eight years running the company, after the charitable foundation that is its main owner called for change. Novo Nordisk's stock had faltered as it encountered competition from rival Eli Lilly and a key developmental drug didn't perform as well at a trial as hoped. \n\n\n     Though not immediately, that move to push out its CEO sparked a 28% rally in the Copenhagen-listed shares. \n\n\n     The Financial Times has reported that an activist investor, Parvus, was building a stake to help influence the appointment of a new CEO. \n\n\n     -Steve Goldstein \n\n\n     This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 13, 2025 04:48 ET (08:48 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"executive","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}